Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Depreciation and Depletion (2016 - 2025)

Chemours (CC) has 12 years of Depreciation and Depletion data on record, last reported at $81.0 million in Q4 2025.

  • For Q4 2025, Depreciation and Depletion rose 3.85% year-over-year to $81.0 million; the TTM value through Dec 2025 reached $328.0 million, up 8.97%, while the annual FY2025 figure was $340.0 million, 12.96% up from the prior year.
  • Depreciation and Depletion reached $81.0 million in Q4 2025 per CC's latest filing, down from $91.0 million in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $91.0 million in Q2 2025 and bottomed at $70.0 million in Q3 2022.
  • Average Depreciation and Depletion over 5 years is $75.8 million, with a median of $75.0 million recorded in 2021.
  • Peak YoY movement for Depreciation and Depletion: dropped 8.97% in 2022, then rose 22.97% in 2025.
  • A 5-year view of Depreciation and Depletion shows it stood at $75.0 million in 2021, then dropped by 4.0% to $72.0 million in 2022, then changed by 0.0% to $72.0 million in 2023, then grew by 8.33% to $78.0 million in 2024, then rose by 3.85% to $81.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation and Depletion were $81.0 million in Q4 2025, $91.0 million in Q2 2025, and $78.0 million in Q4 2024.